Arcutis Biotherapeutics I... (ARQT)
NASDAQ: ARQT
· Real-Time Price · USD
16.80
0.82 (5.13%)
At close: Aug 15, 2025, 2:57 PM
13F Institute Ownership
Total Institutes of 249 in Arcutis Biotherapeutics expanded their positions with an increase of 32 investors compared to the previous quarter. A reduction of 3.83M shares, as total invested capital grew by $32.47M with ownership percentage dropping from 103.66% to 99.19%.
Options Activity
Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.281
0.28
Call Flow 604,500
78%
Put Flow 170,000
22%
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio | Filing Date |
|---|---|---|---|---|---|---|
| Suvretta Capital Management, L... | 9.06% | 11.42M | +0.21% | 178.66M | 6.63% | May 15, 2025 |
| Jennison Associates LLC | 9.01% | 11.36M | -7.93% | 177.68M | 0.12% | May 05, 2025 |
| Rubric Capital Management LP | 8.70% | 10.97M | +0.00% | 171.52M | 3.07% | May 14, 2025 |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.